Expression of ErbB-2 (Her-2/neu) and survivin gene (BIRC5) in tumor infiltrating lymphocytes (TILs) in breast cancer

被引：0
|
作者：
Shlyakhtunou, Y. [1 ]
机构：
[1] Vitebsk State Order Peoples Friendship Med Univ, Vitebsk, BELARUS
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
179
引用
收藏
页码：S16 / S17
页数：5
相关论文
共 50 条
  • [1] Expression of survivin gene (BIRC5) and ErbB-2 (Her-2/neu) in lymphocytes in breast cancer
    Shlyakhtunou, Y.
    Semenov, V.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S105 - S105
  • [2] Tumor progression marker for breast cancer - survivin gene (BIRC5)
    Shlyakhtunou, Y.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S104 - S105
  • [3] erbB-2 (HER-2) and breast cancer progression
    Edgerton, SM
    Moore, D
    Merkel, D
    Thor, AD
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (03) : 214 - 221
  • [4] HER-2/neu (erbB-2) and the cell cycle
    Busse, D
    Doughty, RS
    Arteaga, CL
    SEMINARS IN ONCOLOGY, 2000, 27 (06) : 3 - 8
  • [5] THE BIOLOGY OF ERBB-2 NEU HER-2 AND ITS ROLE IN CANCER
    HYNES, NE
    STERN, DF
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3): : 165 - 184
  • [6] Evaluation of HER-2/neu (erbB-2) status in breast cancer:: From bench to bedside
    Hanna, W
    Kahn, HJ
    Trudeau, M
    MODERN PATHOLOGY, 1999, 12 (08) : 827 - 834
  • [7] HER-2/neu (c-erbB-2) Expression Assessment in Breast Cancer
    Ioanid, N.
    Anton, E.
    Socolov, Demetra
    GINECO RO, 2009, 5 (01): : 43 - 47
  • [8] Tumor infiltrating lymphocytes (TILs) in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Esposito, A.
    Viale, G.
    Curigliano, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [9] CLINICAL-SIGNIFICANCE OF ERBB-2 (HER-2/NEU) PROTEIN
    PAIK, SM
    CANCER INVESTIGATION, 1992, 10 (06) : 575 - 579
  • [10] Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu):: A study of incidence and correlation with outcome in breast cancer
    Thor, AD
    Liu, S
    Edgerton, S
    Moore, D
    Kasowitz, KM
    Benz, CC
    Stern, DF
    DiGiovanna, MP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3230 - 3239
12345